U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H9N3O2.ClH
Molecular Weight 167.594
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CREATINE HYDROCHLORIDE

SMILES

Cl.CN(CC(O)=O)C(N)=N

InChI

InChIKey=DGOAYHVIVJYHKU-UHFFFAOYSA-N
InChI=1S/C4H9N3O2.ClH/c1-7(4(5)6)2-3(8)9;/h2H2,1H3,(H3,5,6)(H,8,9);1H

HIDE SMILES / InChI

Molecular Formula C4H9N3O2
Molecular Weight 131.1332
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Creatine is an amino acid that occurs in vertebrate tissues and in urine. It is synthesized mainly in the liver from three different amino acids: arginine, glycine, and methionine. In skeletal muscles, which store 95% of it, creatine generally occurs as phosphocreatine. The rest is stored in the brain, heart, and testes. Creatine functions as part of the cell's energy shuttle. It is excreted as creatinine in the urine.

Approval Year

PubMed

PubMed

TitleDatePubMed
Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder.
2001 Apr
Neuroprotective effects of MK-801 on L-2-chloropropionic acid-induced neurotoxicity.
2001 Feb
Phosphorylation-dependent alteration in myofilament ca2+ sensitivity but normal mitochondrial function in septic heart.
2001 Feb
Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats.
2001 Feb
Protection against cellular damage in the rat heart by iodoacetate.
2001 Feb
Release of muscle proteins after downhill running in male and female subjects.
2001 Feb
Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running.
2001 Feb
Uremic concentrations of guanidino compounds inhibit neutrophil superoxide production.
2001 Feb
Altered activities of rat brain metabolic enzymes caused by pentylenetetrazol kindling and pentylenetetrazol--induced seizures.
2001 Feb
Reproducibility of hippocampal single-Voxel proton MR spectroscopy and chemical shift imaging.
2001 Feb
Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning.
2001 Feb
Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation.
2001 Feb
Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
2001 Feb
Emergency department evaluation of chest pain using exercise stress echocardiography.
2001 Feb
Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MB(mass).
2001 Feb
Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.
2001 Feb
Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1.
2001 Feb 1
Structure of an intermediate in the unfolding of creatine kinase.
2001 Feb 1
Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha.
2001 Feb 6
Deterioration in renal function associated with fibrate therapy.
2001 Jan
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
2001 Jan
Exercise training increases creatine kinase capacity in canine myocardium.
2001 Jan
Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with real-time needle placement.
2001 Jan
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
2001 Jan
Systemic effects of hyperthermic isolated lower limb perfusion with carboplatin and interferon-beta.
2001 Jan
Pretreatment of human myocardium with adenosine.
2001 Jan
Myoglobin and creatine kinase isoenzyme MB mass assays: intermethod behaviour of patient sera and commercially available control materials.
2001 Jan
Proton MR spectroscopy in patients with acute temporal lobe seizures.
2001 Jan
Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.
2001 Jan
Transient QT interval prolongation with inverted T waves indicates myocardial salvage on dual radionuclide single-photon emission computed tomography in acute anterior myocardial infarction.
2001 Jan
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.
2001 Jan
Q-wave evolution of a first acute myocardial infarction without significant ST segment elevation.
2001 Jan
Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization.
2001 Jan
Role of exercise and ascorbate on plasma antioxidant capacity in thoroughbred race horses.
2001 Jan
Creatine supplementation increases renal disease progression in Han:SPRD-cy rats.
2001 Jan
Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
2001 Jan
Prenatal programming of adult hypertension in the rat.
2001 Jan
Validity of NIR spectroscopy for quantitatively measuring muscle oxidative metabolic rate in exercise.
2001 Jan
Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.
2001 Jan
Supplemental creatine may decrease serum homocysteine and abolish the homocysteine 'gender gap' by suppressing endogenous creatine synthesis.
2001 Jan
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies.
2001 Jan
Varicella myocarditis in an adult.
2001 Jan
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
2001 Jan 1
Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
2001 Jan 20
Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
2001 Jan 6
Use of ergogenic aids by athletes.
2001 Jan-Feb
Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
2001 Mar
IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart.
2001 Mar
An (1)H-MRS evaluation of the phosphocreatine/creatine pool (tCr) in human muscle.
2001 Mar
Creatine transporter protein content, localization, and gene expression in rat skeletal muscle.
2001 Mar
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:53:46 GMT 2023
Edited
by admin
on Sat Dec 16 10:53:46 GMT 2023
Record UNII
429W5UKC8E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CREATINE HYDROCHLORIDE
Systematic Name English
GLYCINE, N-(AMINOIMINOMETHYL)-N-METHYL-, HYDROCHLORIDE (1:1)
Systematic Name English
Creatine hydrochloride [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
429W5UKC8E
Created by admin on Sat Dec 16 10:53:47 GMT 2023 , Edited by admin on Sat Dec 16 10:53:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID50937776
Created by admin on Sat Dec 16 10:53:47 GMT 2023 , Edited by admin on Sat Dec 16 10:53:47 GMT 2023
PRIMARY
PUBCHEM
134732
Created by admin on Sat Dec 16 10:53:47 GMT 2023 , Edited by admin on Sat Dec 16 10:53:47 GMT 2023
PRIMARY
CAS
17050-09-8
Created by admin on Sat Dec 16 10:53:47 GMT 2023 , Edited by admin on Sat Dec 16 10:53:47 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE